Category: HypertensionSyndicate content

Hypertension: CVRx wins FDA nod for Barostim neo legacy

December 17, 2014 by Val Kennedy

The FDA grants a humanitarian device exemption for CVRx's Barostim neo legacy device for treating drug-resistant hypertension.

Hypertension: CVRx wins FDA nod for Barostim neo legacy

CVRx said yesterday that it won a humanitarian device exemption from the FDA for its Barostim neo legacy device, to treat drug-resistant hypertension.

Renal denervation: Analysis highlights 'confounding' factors in Medtronic's Symplicity-3 trial

December 10, 2014 by Brad Perriello

An analysis of Medtronic's failed Symplicity-3 renal denervation trial highlights several 'confounding' factors that may have contributed to a missed efficacy endpoint, suggesting a way forward for more RDN studies.

Renal denervation: Analysis highlights 'confounding' factors in Medtronic's Symplicity-3 trial

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Vascular Dynamics raises $10m

November 7, 2014 by Val Kennedy

Vascular Dynamics reports raising $10 million out of a hoped-for $23 million funding round for its MobiusHD anti-hypertension implant.

Vascular Dynamics raises $10m

Vascular Dynamics said it raised nearly $10 million from a group of unnamed investors for the hypertension implant it's developing.

The Mountain View, Calif.-based startup reported raising $9.7 million in an offering of stock, warrants and other securities as part of a proposed $22.9 million funding round.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Stealth hypertension startup Sympara Medical raises nearly $6m

October 23, 2014 by Alexander Soule

Sympara Medical quietly secures $5.5 million in funding from a handful of investors as it develops a device to treat hypertension.

Stealth hypertension startup Sympara Medical raises nearly $6m

Stealthy Sympara Medical quietly secured $5.5 million in funding from a handful of investors for the hypertension device it's developing.

San Francisco-based Sympara disclosed the funding in a regulatory filing, after recording $4.3 million with the SEC in 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Ablative Solutions tests infusion ablation catheter as hypertension treatment

October 20, 2014 by Alexander Soule

Ablative Solutions begins testing its infusion ablation catheter as a potential treatment for hypertension.

Ablative Solutions tests infusion ablation catheter as hypertension treatment

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

TCT 2014: Another trial shows no benefit for renal denervation in hypertension

September 17, 2014 by Brad Perriello

Another trial of Medtronic's Symplicity renal denervation device in treating hypertension shows no benefit compared with a sham procedure.

TCT 2014: Another Medtronic trial shows no benefit for renal denervation in hypertension

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

TCT 2014 Roundup

September 15, 2014 by Brad Perriello

A roundup of studies released at the annual Transcatheter Cardiovascular Therapies conference in Washington this week.

TCT 2014 Roundup

Here's a look at some of the news coming out of Washington at the 26th annual Transcatheter Cardiovascular Therapies conference this week:

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp